United States

People: GenVec Inc (GNVC.O)

GNVC.O on Consolidated Issue listed on NASDAQ Capital Market

21 Oct 2016
Change (% chg)

$-0.00 (-0.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Butman, Bryan 

Dr. Bryan T. Butman, Ph.D., is Senior Vice President of Development of GenVec, Inc. He joined GenVec in 1999 and previously served as GenVec’s Vice President of Vector Operations (2005 to 2006), Vice President of Quality (2002 to 2005) and Director of Quality and Analytical Science (1999 to 2002). Prior to joining GenVec, Dr. Butman was Executive Director of Diagnostic Product Research and Development with INTRACEL Corporation, a biotechnology company. Dr. Butman has over 30 years of biotechnology product development experience including clinical gene therapy, human monoclonal antibody and clinical diagnostic products. Throughout his biotechnology career, Dr. Butman has developed successful products in the areas of oncology, cardiovascular disease, infectious disease, food safety and hematology. He has held senior positions within Warner Lambert, AKZO-Nobel, Organon Teknika, PerImmune and INTRACEL. Dr. Butman holds a Ph.D. in Cell Biology from Wayne State University.

Basic Compensation

Total Annual Compensation, USD 278,060
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 193,277
Fiscal Year Total, USD 471,337

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --